David LAGIER, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM

Por um escritor misterioso

Last updated 15 junho 2024

Karine BAUMSTARCK, Medical Doctor, MD, PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM, Délégation à la Recherche Clinique et à l'innovation

David LAGIER, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM

Efficacité de l'hydroxychloroquine et de l'azithromycine

X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. - Abstract - Europe PMC

X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

David LAGIER, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM

Sarah Lemoine - AHU - CHU de Nantes

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

David LAGIER, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM

X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. - Abstract - Europe PMC

PDF) Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

David LAGIER, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM

Recomendado para você